Related Experiment Video

Updated: Aug 20, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.0K

Author Reply: In Response to "De Novo KRAS G12C-Mutant SCLC: A Case Report"

Meridith L Balbach1,2, Rosana Eisenberg3,4, Wade T Iams1,3

  • 1Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

JTO Clinical and Research Reports
|November 21, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.2K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K

Related Experiment Videos

Last Updated: Aug 20, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
07:45

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

8.0K
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.2K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

25.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K

Articles linked to this work by shared authors, journal, and citation graph.

Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Associated Sicca Syndrome.

Cancers·2026

Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors.

Cancer research communications·2025

Tepotinib in patients with MET exon 14 skipping non-small cell lung cancer.

Cancer treatment reviews·2025

Two Cases of Amivantamab-Induced Pneumonitis in Patients With NSCLC: Case Report.

JTO clinical and research reports·2025

Body composition as a potential biomarker of recurrence risk in patients with triple-negative breast cancer.

Breast cancer research and treatment·2025

Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 rearranged non-small cell lung cancer: A case report.

Oncotarget·2025

Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.

JTO clinical and research reports·2026

EGFR-Mutant Non-Small Cell Lung Cancer With Small Cell Transformation: Clinicopathological Features, Treatment Landscape, and Biomarker Profiles.

JTO clinical and research reports·2026

Pre-treatment Tumor Volume Growth Rate and Baseline Volume Measured by an Artificial Intelligence Program Predict Overall Survival in Patients With Pleural Mesothelioma Undergoing Deferred Systemic Therapy.

JTO clinical and research reports·2026

Safety Evaluation of Tarlatamab in SCLC: A Systematic Review and Meta-Analysis.

JTO clinical and research reports·2026

Response to Trastuzumab Deruxtecan in a Patient With EGFR-Mutated NSCLC and Transformation to SCLC Harboring HER2 Amplification: A Case Report.

JTO clinical and research reports·2026

Single- Versus Multi-Fraction Stereotactic Body Radiotherapy for Primary Lung Cancer and Pulmonary Oligometastases: A Systematic Review and Meta-Analyses.

JTO clinical and research reports·2026

Multidimensional Voice Outcomes in Cisgender Women Following Exogenous Testosterone Therapy.

Journal of voice : official journal of the Voice Foundation·2026

Protecting or Excluding? Ethical Tensions in Integrated Care Research with People with Complex Needs.

International journal of integrated care·2026

Professional identity and engagement in oral health promotion activities among oral health ambassadors in China: a national cross-sectional survey.

Frontiers in public health·2026

Harm Reduction-Oriented Occupational Therapy for Substance Use Disorders: A Retrospective Cohort Study.

The American journal of occupational therapy : official publication of the American Occupational Therapy Association·2026

From Clinic to Home: Validating the Social Communication Scale for Telemedicine-Supported Early Autism Screening in Chinese Toddlers.

Autism : the international journal of research and practice·2026

Minimal Clinically Important Difference on the Social Responsiveness Scale in Autistic Children Aged 4 to 10 Years.

Autism : the international journal of research and practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us